Associate Research Fellow
Sir Henry Wellcome Building for Mood Disorders Research Room F07
Sir Henry Wellcome Building for Mood Disorders Research, University of Exeter, Queens Drive, Exeter, EX4 4QQ, UK
Faith Warner is a Postdoctoral Research Fellow and the Trial Manager on the THRIVE-B trial. This study looks at a new talking therapy for people who have Bipolar Disorder or Cyclothymic Disorder, and experience frequent mood swings: the THRIVE-B programme. This programme is suitable for people with frequent mood swings within Bipolar Disorder, and teaches skills for responding to rapid mood shifts and the sort of everyday life events that can trigger off mood changes. Faith joined the Mood Disorders Centre in 2018 to work as Trial Manager on the THRIVE-B programme. Prior to this, Faith worked on INTERTREAD (a drug trial with the aim to reduce hypoglycaemia events in frail elderly people on insulin) at the Exeter Clinical Trials Unit as a Postdoctoral Research Associate and on COBRA as an Associate Research Fellow. COBRA was a multi-centre randomised controlled trial funded by the UK National Institute for Health Research (NIHR) Health Technology Assessment Programme, led by Professor David Richards, NIHR Senior Investigator and head of the Complex Interventions Research Group.
- Master of Science
- BSc in Psychology
- Introduction to Good Clinical Practice (GCP) e-learning – 2014
- Structured Clinical Interview for DSMIV Axis 1 Disorders Training 2014
- NHS Honorary contract as a Research Fellow
- NHS letter of Access for Research
- Risk and Reporting of Adverse Events Training 2014
- Certificate in Teaching and Learning at the University of Exeter 2005
Faith has research interests in therapeutic intervention in depression, particularly Behavioural Activation, alongside general interests in mental health, particularly anxiety and depression. Research interests in the past have focused on cognition and future interests include the effect of mood on cognitive functioning.
Faith is currently an Associate Research Fellow on the COBRA trial in the Medical School. COBRA is a Randomised Controlled Clinical Trial of two psychological interventions – Behavioural Activation (BA) and Cognitive Behaviour Therapy (CBT) – to establish whether there are important clinical and cost differences between them.